Earnings Scheduled For May 16, 2022
Companies Reporting Before The Bell
• AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.
Preview: Rockwell Medical’s Earnings
Rockwell Medical (NASDAQ:RMTI) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement.
Analysts estimate that Rockwell Medical will report an earnings per share (EPS) of $-0.09.
90 Biggest Movers From Yesterday
Gainers
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.
Rockwell Medical Submits Additional Data For IND Application For Iron Deficiency Candidate
Rockwell Medical Inc (NASDAQ:RMTI) has provided the FDA with the supplemental data requested by the agency in December 2021 for its…
The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More
Here's a roundup of top developments in the biotech space over the last 24 hours:
Rockwell Medical Announces 1-for-11 Reverse Stock Split, Effective May 13
WIXOM, Mich., May 12, 2022 /PRNewswire/ -- Rockwell Medical, Inc. (NASDAQ:RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management, today announced that its
Rockwell Medical Announces Completion Of Patient Enrollment Ahead Of Schedule In Pivotal Phase 3 Clinical Trial Of Triferic In China
Rockwell Medical, Inc. (NASDAQ:RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management, today announced that its partner, Wanbang
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers
Rockwell Medical (NASDAQ:RMTI) stock rose 9.2% to $0.4 during Monday's after-market session. The company's market cap stands at $37.5 million.
Rockwell Medical’s Return On Capital Employed Insights
Benzinga Pro data, Rockwell Medical (NASDAQ:RMTI) reported Q4 sales of $15.33 million. Earnings fell to a loss of $8.94 million, resulting in a 17.94% decrease from last quarter.